moxisylyte has been researched along with Flaccid Quadriplegia in 3 studies
Moxisylyte: An alpha-adrenergic blocking agent that is used in Raynaud's disease. It is also used locally in the eye to reverse the mydriasis caused by phenylephrine and other sympathomimetic agents. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1312)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Mathias, CJ | 2 |
Unwin, RJ | 2 |
Pike, FA | 1 |
Frankel, HL | 2 |
Sever, PS | 1 |
Peart, WS | 2 |
Corbett, JL | 1 |
Eidelman, BH | 1 |
1 trial available for moxisylyte and Flaccid Quadriplegia
Article | Year |
---|---|
The immediate pressor response to saralasin in man: evidence against sympathetic activation and for intrinsic angiotensin II-like myotropism.
Topics: Adult; Aldosterone; Blood Pressure; Female; Heart Rate; Humans; Male; Moxisylyte; Muscle, Smooth, Va | 1984 |
2 other studies available for moxisylyte and Flaccid Quadriplegia
Article | Year |
---|---|
Renal vascular responses to saralasin in conscious chemically denervated rabbits and patients with tetraplegia.
Topics: Adult; Angiotensin II; Animals; Consciousness; Female; Glomerular Filtration Rate; Guanethidine; Hum | 1986 |
Studies on cerebral circulation in man indicating presence of neurogenic control.
Topics: Adult; Blood Pressure; Blood Vessels; Brain; Carbon Dioxide; Cerebrovascular Circulation; Constricti | 1973 |